Products

What will AGI do for Arotinolol?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H21N3O2S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 394E3P3B99, chemically known as 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide but generally known as arotinolol, which bears US NIH Compound Identifier 2239. Arotinolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Arotinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05568MIG. The term AROTINOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). AROTINOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule arotinolol under HS 29341000 and SITC 51579. As of Q4 2014, AROTINOLOL remains the US FDA Preferred Term for this commodity. Arotinolol bears US NLM identifiers UMLS ID C0104221 and NCI Concept Code C72609. SMILES: S(CC(O)CNC(C)(C)C)C1SCC(N1)C1SC(CC1)C(=O)N.